Biomea Fusion Inc. (BMEA) NASDAQ
$11.50 (0.45) (-3.77%)
Market Cap: $412.73M
As of 04/17/24 04:00 PM EDT. Market closed.
Biomea Fusion Inc. (BMEA)
NASDAQ
$11.50
(0.45) (-3.77%)
Market Cap: $412.73M
As of 04/17/24 04:00 PM EDT. Market closed.
biomea fusion, llc was formed in 2017 by a small group of biotech executives. we are dedicated to developing innovative medicines for patients. it is our goal to design and clinically develop patient friendly therapies with higher efficacy than the current standard of care. the more precise a therapeutic agent is, the better the potential outcomes for individual patients’ needs. we are a ... read more
biomea fusion, llc was formed in 2017 by a small group of biotech executives. we are dedicated to developing innovative medicines for patients. it is our goal to design and clinically develop patient friendly therapies with higher efficacy than the current standard of care. the more precise a therapeutic agent is, the better the potential outcomes for individual patients’ needs. we are a precision oncology company developing novel small molecules that target aggressive forms of cancer. patients with these aggressive tumors typically exhibit high mortality rates and suffer from inadequate treatment options. with our current program, we are targeting specific changes to the dna of patients, which can be isolated as key drivers for tumor growth. we leverage our internal expertise and compliment it with computational drug design technology to build novel medicines for the future. we have significantly invested in the upfront development of our targeted therapies and are conducting bro read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Valle Franco | Chief Financial Officer | Nov 30, 2023 | Option Exercise | $3.78 | 1,345 | 5,087 | 25,543 | Dec 01, 2023, 05:58 PM |
Valle Franco | Chief Financial Officer | May 31, 2023 | Option Exercise | $3.78 | 4,273 | 16,163 | 24,198 | Jun 02, 2023, 05:01 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | Jun 01, 2023 | Sale | $34.56 | 50,000 | 1,728,165 | 3,500,000 | Jun 02, 2023, 05:00 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | May 31, 2023 | Sale | $33.81 | 75,000 | 2,535,750 | 3,550,000 | Jun 02, 2023, 05:00 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | May 12, 2023 | Sale | $33.84 | 25,000 | 846,000 | 3,625,000 | May 17, 2023, 07:13 AM |
A2A Pharmaceuticals, Inc. | 10% Owner | May 09, 2023 | Sale | $34.50 | 150,000 | 5,175,720 | 3,650,000 | May 10, 2023, 05:19 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | May 08, 2023 | Sale | $33.99 | 100,000 | 3,399,310 | 3,800,000 | May 10, 2023, 05:19 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | Apr 20, 2023 | Sale | $29.12 | 200,000 | 5,823,760 | 3,900,000 | Apr 26, 2023, 08:36 AM |
A2A Pharmaceuticals, Inc. | 10% Owner | Mar 31, 2023 | Sale | $31.25 | 200,000 | 6,250,000 | 4,100,000 | Apr 06, 2023, 07:31 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | Mar 31, 2023 | Sale | $31.25 | 200,000 | 6,250,000 | 4,100,000 | Apr 06, 2023, 06:43 PM |
Chen Bihua | Director | Mar 30, 2023 | Buy | $30.00 | 400,000 | 12,000,000 | 3,570,872 | Apr 03, 2023, 04:30 PM |
Erdtmann Rainer M | President and COO | Apr 15, 2021 | Buy | $17.00 | 3,000 | 51,000 | 3,000 | Feb 10, 2023, 04:10 PM |
Erdtmann Rainer M | President and COO | Apr 15, 2021 | Buy | $17.00 | 5,400 | 91,800 | 3,000 | Feb 10, 2023, 04:10 PM |
Valle Franco | Chief Financial Officer | Nov 30, 2022 | Option Exercise | $3.78 | 2,518 | 9,524 | 19,925 | Dec 02, 2022, 04:30 PM |
Hitchcock Michael J.M. | Director | Nov 14, 2022 | Buy | $7.93 | 5,000 | 39,650 | 5,000 | Nov 16, 2022, 04:30 PM |
Valle Franco | Chief Financial Officer | Nov 11, 2022 | Buy | $7.63 | 4,100 | 31,286 | 17,407 | Nov 14, 2022, 04:30 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | Aug 16, 2022 | Buy | $13.87 | 30,684 | 425,648 | 4,300,000 | Aug 19, 2022, 06:56 AM |
A2A Pharmaceuticals, Inc. | 10% Owner | Jul 21, 2022 | Sale | $11.21 | 34,658 | 388,516 | 4,330,684 | Jul 25, 2022, 07:16 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | Jun 24, 2022 | Sale | $11.76 | 34,658 | 407,578 | 4,365,342 | Jun 28, 2022, 07:51 AM |
Valle Franco | Chief Financial Officer | May 31, 2022 | Option Exercise | $4.67 | 3,307 | 15,432 | 13,307 | Jun 01, 2022, 06:00 PM |
Valle Franco | Chief Financial Officer | Jan 14, 2022 | Buy | $8.68 | 10,000 | 86,767 | 10,000 | Jan 18, 2022, 07:00 PM |
A2A Pharmaceuticals, Inc. | 10% Owner | Sep 17, 2021 | Buy | $10.96 | 34,658 | 379,852 | 4,400,000 | Sep 21, 2021, 04:05 PM |
Stergiopoulos Sotirios | Director | Sep 17, 2021 | Buy | $10.96 | 34,658 | 379,852 | 4,400,000 | Sep 21, 2021, 04:05 PM |
Erdtmann Rainer M | President & COO | Aug 23, 2021 | Buy | $13.20 | 24,000 | 316,872 | 228,470 | Aug 25, 2021, 08:56 PM |
Butler Thomas Andrew | CEO | Aug 23, 2021 | Buy | $13.20 | 24,000 | 316,872 | 228,470 | Aug 25, 2021, 08:55 PM |
Erdtmann Rainer M | President & COO | Apr 15, 2021 | Buy | $17.00 | 176,470 | 2,999,990 | 176,470 | Aug 19, 2021, 09:41 PM |
Erdtmann Rainer M | President & COO | Aug 18, 2021 | Buy | $10.77 | 14,000 | 150,738 | 204,470 | Aug 19, 2021, 09:41 PM |
Erdtmann Rainer M | President & COO | Aug 17, 2021 | Buy | $10.79 | 14,000 | 151,067 | 190,470 | Aug 19, 2021, 09:41 PM |
Butler Thomas Andrew | CEO | Aug 18, 2021 | Buy | $10.77 | 14,000 | 150,738 | 204,470 | Aug 19, 2021, 09:40 PM |
Butler Thomas Andrew | CEO | Aug 17, 2021 | Buy | $10.79 | 14,000 | 151,067 | 190,470 | Aug 19, 2021, 09:40 PM |
Butler Thomas Andrew | CEO | Apr 15, 2021 | Buy | $17.00 | 176,470 | 2,999,990 | 176,470 | Aug 19, 2021, 09:40 PM |
Chen Bihua | Director | Apr 20, 2021 | Buy | $17.00 | 900,000 | 15,300,000 | 3,170,872 | Apr 22, 2021, 04:09 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 2,156,342 | 0.0008% | 4.26% | Other |
BAKER BROS. ADVISORS LP | 2,108,949 | 0.35% | No change | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,182,741 | 0.21% | 29.56% | Growth |
GEODE CAPITAL MANAGEMENT, LLC | 480,322 | 0.00073% | 5.97% | Other |
D. E. SHAW & CO., INC. | 52,994 | 0.00067% | New | Other |
ALPS ADVISORS INC | 30,399 | 0.00347% | New | Other |
BALYASNY ASSET MANAGEMENT L.P. | 22,428 | 0.00061% | New | Event Driven |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,206 | 0.003% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View